Zosano Pharma Corporation
USD0.56
+0.00 (+0.00%)
CEO
Steven Lo
IPO Date
2015-01-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.52
Prev. Close
$0.56
Day Low
$0.46
Day High
$0.64
52W Low
$0.11
52W High
$7.63
Volume
1.16M
| 442 |
| $0.71 |
| 1 Apr 2022 | Matthews Christine | Chief Financial Officer | S-Sale | Disposed | 8,116 | $0.21 |
| 1 Apr 2022 | KELLERMAN DONALD J | VP, Clinical Dev & Med Affairs | S-Sale | Disposed | 4,006 | $0.21 |
| 1 Apr 2022 | Lo Steven | Chief Executive Officer | S-Sale | Disposed | 23,633 | $0.21 |
| 24 Nov 2021 | GREATHOUSE KENNETH | director | S-Sale | Disposed | 10,000 | $0.60 |
| 19 Oct 2021 | Matthews Christine | Chief Financial Officer | A-Award | Acquired | 56,250 | $0.00 |
| 19 Oct 2021 | Matthews Christine | Chief Financial Officer | A-Award | Acquired | 112,500 | $0.63 |
| 19 Oct 2021 | KELLERMAN DONALD J | VP, Clinical Dev & Med Affairs | A-Award | Acquired | 10,000 | $0.00 |
| 19 Oct 2021 | KELLERMAN DONALD J | VP, Clinical Dev & Med Affairs | A-Award | Acquired | 20,000 | $0.63 |